Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2024;35(1):94-107
Article Links
Aetiology of Vascular Purpura in a Single Centre Experience: Contribution of Clinical and Paraclinical Data
Amira El Ouni, Faiza Ben Messaoud, Rym Khayati, C Abdelkafi, Zeineb Meddeb, Saloua Hamzaoui, Thara Larbi, Sana Toujani, Kamel Bouslama
Authors Information

CHU Mongi Slim, La Marsa, Tunisia

F Ben Messaoud

Keywords: vascular purpura, cutaneous leucocytoclastic vasculitis, aetiology
References
  1. Crickx B, Piette F, Roujeau JC, Bonnetblanc JM. Purpuras chez l’adulte. Ann Dermatol Venereol 2002;129(2):S219-23.
  2. Tai YJ, Chong AH, Williams RA, Cumming S, Kelly RI. Retrospective analysis of adult patients with cutaneous leukocytoclastic vasculitis. Australas J Dermatol 2006;47(2):92-6.
  3. Khetan P, Sethuraman G, Khaitan BK, Sharma VK, Gupta R, Dinda AK, et al. An aetiological and clinicopathological study on cutaneous vasculitis. Indian J Med Res 2012;135(1):107.
  4. Arora A, Wetter DA, Gonzalez-Santiago TM, Davis MDP, Lohse CM. Incidence of leukocytoclastic vasculitis, 1996 to 2010: A population-based study in Olmsted County, Minnesota. Mayo Clin Proc 2014;89(11):1515-24.
  5. Aounallah A, Arouss A, Ghariani N, Saidi W, Sriha B, Denguezli M, et al. Vascularites cutanées leucocytoclasiques: à propos de 85 cas. Pan Afr Med J 2017;26:138.
  6. Al-Mutairi N. Spectrum of cutaneous vasculitis in adult patients from the Farwaniya region of Kuwait. Med Princ Pract 2008;17:43-8.
  7. Leelavathi M. Cutaneous vasculitis: A review of aetiology and clinical manifestations in 85 patients in Malaysia. Med J Malasyia 2009;64(3):210-2.
  8. Swapna B, Jyothirani ER, Riyas N. A clinicopathological study of cutaneous small vessel vasculitis in a tertiary care centre from North Kerala. J Evid Based Med Healthc 2018;5(2):188-93.
  9. Cakiter AU, Kucuk OS, Ozkaya DB, Topukcu B, Onsun N. Demographic characteristics, aetiology, and assessment of treatment options in leukocytoclastic vasculitis. Postepy Dermatol Alergol 2017;34(2):104-9.
  10. Samson M, Bouiller K, Audia S, Devilliers H, Collet E, Aubriot-Lorton MH, et al. Étiologie et facteurs pronostiques des vascularites leucocytoclasiques: étude rétrospective (112 patients). Rev Med Interne 2015;36 Suppl 2:A46-7.
  11. Karaosmanoglu N, Ozdemir Cetinkaya P, Karaaslan E. Leukocytoclastic vasculitis: A retrospective analysis of 57 cases. Cyprus J Med Sci 2019;4(3):242-6.
  12. Loricera J, Blanco R, Hernández JL, Calvo-Río V, Ortiz-Sanjuán F, Mata C, et al. Cutaneous vasculitis associated with severe bacterial infections. A study of 27 patients from a series of 766 cutaneous vasculitis. Clin Exp Rheumatol 2015;33 Suppl 89:S36-43.
  13. Klii R, Letaief K, Chaaben I, Youssef M, Kechida M, Zili J, et al. Profil des purpuras vasculaires: à propos de 48 cas. Rev Med Interne 2015;36 Suppl 1:A81.
  14. Frikha F, Hariz H, Snoussi M, Salah RB, Damak C, Turki C, et al. Particularités du purpura vasculaire du sujet âgé. Rev Med Interne 2016;37 Suppl 2:A148.
  15. Ben Yahia W, Ghannouchi N, Bouker A, Atig A, Bahri F. Profil étiologique des purpuras vasculaires: à propos de 44 cas. Rev Med Interne 2015;36 Suppl 1:A79.
  16. Laanani A, Ben Salem T, Mejri M, Hamzaoui A, Khanfir M, Said F, et al. Profil étiologique des purpuras vasculaires: à propos de 131 patients. Rev Med Interne. 2014;35(2):158-9.
  17. Bagai A, Albert S, Shenoi SD. Evaluation and therapeutic outcome of palpable purpura. Indian J Dermatol Venereol Leprol. 2001;67(6):320-3.
  18. Toujani S, Daoud F, Aydi Z, Baili L, Ben Dhaou B, Boussefa F. Les vascularites cutanées en médecine interne: à propos de 58 cas. Rev Med Interne 2015;36:A81-2.
  19. Ortiz-Sanjuán F, Blanco R, Hernández JL, Pina T, González-Vela MC, Fernández-Llaca H, et al. Drug-associated cutaneous vasculitis: study of 239 patients from a single referral center. J Rheumatol 2014;41(11):2201-7.
  20. Sáenz de Santa María García M, Morales-Cabeza C, Noguerado-Mellado B, Rojas-Pérez-Ezquerra P, Zubeldia JM. Cutaneous leukocytoclastic vasculitis due to amoxicillin hypersensitivity. Ann Allergy Asthma Immunol 2016;117(4):446-7.
  21. Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology 2010;56(1):3-23.
  22. Jung AJ, Schaeffer M, Mitcov M, Scrivener Y, Cribier B, Lipsker D. Étude anatomo-clinique du purpura: y a-t-il un intérêt à biopsier un purpura palpable? Ann Dermatol Venereol 2016;143(5):347-53.
  23. Francès C, Kluger N, Doutre MS. Vasculites cutanées et cutanéosystémiques. EMC - Dermatologie 2011;6(3):1-19.
  24. Frumholtz L, Aumaître O, Maurier F, Ruivard M, Laurent S, Puéchal X, et al. Manifestations cutanées au cours des vascularites associées aux ANCA: étude dans une cohorte de 1535 patients. Rev Med Interne 2015;36 Suppl 2:A 47-8.
  25. Ioannidou DJ, Krasagakis K, Daphnis EK, Perakis KE, Sotsiou F, Tosca AD. Cutaneous small vessel vasculitis: an entity with frequent renal involvement. Arch Dermatol 2002;138(3):412-4.
  26. Godeau B. Quand penser à une maladie systémique en réanimation? Reanimation 2005;14(7):563-8.
  27. Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis 2019;68(10):e83-110.
  28. Ivanov M, Malinverni R. Bactériurie asymptomatique chez l’adulte: prise en charge différenciée. Rev Med Suisse 2008;4(179):2452-6.
  29. Baeteman C, Guyot L, Bouvenot J, Chossegros C, Cheynet F, Loudot C, et al. Faut-il encore effectuer des biopsies des glandes salivaires accessoires? Rev Stomatol Chir Maxillofac 2008;109(3):143-7.
  30. Lath K, Chatterjee D, Saikia UN, Saikia B, Minz R, De D, et al. Role of direct immunofluorescence in cutaneous small-vessel vasculitis: Experience From a Tertiary Center. Am J Dermatopathol 2018;40(9):661-6.
  31. Kataoka H, Tomita T, Kondo M, Mukai M. Presence of purpura is related to active inflammation in association with IL-5 in eosinophilic granulomatosis with polyangiitis. Rheumatol Int 2020;40(1):1-6.
  32. Fathallah N, Ouni B, Mokni S, Baccouche K, Atig A, Ghariani N, et al. Vascularites médicamenteuses: à propos d’une série de 13 cas. Therapies. 2019;74(3):347-54.
  33. El Chami S, Jibbe A, Shahouri S. Bacterial Endocarditis Presenting as Leukocytoclastic Vasculitis. Cureus 2017;9(7):e1464.
  34. Natarajan A, Hindocha D, Kular N, Fergey S, Davis JR. Vasculitic rash: do not jump to conclusions. Clin Med (Lond) 2012;12(2):179-80.
  35. Kefi A, Kammoun S, Elleuch M, Helali W, Jaziri F, Ben Abdelghani K, et al. Hérédité et maladies systémiques: le jeu de 14 familles. Rev Med Interne.2019;40:A157.
  36. Adinolfi LE, Mangoni ED, Marrone A, Zampino R, Rinaldi L. Viral Hepatitis C. In: Radu-Ionita F, Pyrsopoulos NT, Jinga M, Tintoiu IC, Sun Z, Bontas E, eds. Liver Diseases. Cham: Springer; 2020. p. 181-95.
  37. Stack J, Ryan J, McCarthy G. Colchicine: New Insights to an Old Drug. Am J Ther 2015;22(5):151-7.
  38. Carlson JA, Cavaliere LF, Grant-Kels JM. Cutaneous vasculitis: diagnosis and management. Clin Dermatol 2006;24(5):414-29.
  39. Anila P, Guru P, Padmasri Y, Priyadarshini T, Rajesh G, Jyothi N, et al. Leucocytoclastic vasculitis: A clinicopathological study. J Evol Med Dent Sci 2015;4(81):14201-6.
  40. Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, aetiology, pathogenesis, evaluation, and prognosis. Am J Dermatopathol 2005;27(6):504-28.
  41. Lévesque H, Marie I. Infection et purpura vasculaire. J Mal Vascul 1999;24(3):177.
  42. Cohen P, Guillevin L. Vascularites associées aux infections virales. Presse Med 2004;33(19):1371-84.
  43. Dominguez-Santas M, Diaz-Guimaraens B, Garcia Abellas P, Moreno-Garcia Del Real C, Burgos-Blasco P, Suarez-Valle A. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19). J Eur Acad Dermatol Venereol 2020;34(10):e536-7.
  44. Lévesque H. Purpura vasculaire. In: Claessens YE, Mouthon L, dir. Maladies rares en médecine d’urgence. Paris: Springer; 2013. p. 173-87.
  45. Drozd B, Andriescu E, Suárez A, de la Garza Bravo MM. Cutaneous cytomegalovirus manifestations, diagnosis, and treatment: a review. Dermatol Online J 2019;25(1):1-9.
  46. Esaki H, Otsubo Y, Sumi M, Moriuchi M, Moriuchi H. Purpuric skin lesions possibly associated with acquired cytomegalovirus infection. Pediatr Int 2019;61(5):522-3.
  47. Arslan F, Batirel A, Mert A, Ozer S. Cytomegalovirus (CMV)-related cutaneous necrotizing vasculitis: case report and literature review. Braz J Infect Dis 2012;16(5):482-5.
  48. Sène D, Cacoub P. Manifestations extrahépatiques au cours de l’infection par le virus de l’hépatite C. Encycl Med Chir. (Elsevier Masson, Paris), Hépatologie 2010;7-015-B-90.
  49. Terrier B, Cacoub P. Virus de l’hépatite B, manifestaions extrahépatiques immunologiques et risque de réactivation virale. Rev Med Interne 2011;32(10):622-7.
  50. Gupta S, Handa S, Kanwar AJ, Radotra BD, Minz RW. Cutaneous vasculitides: Clinico-pathological correlation. Indian J Dermatol Venereol Leprol 2009;75(4):356.
  51. Kort Y, Khammassi N. Purpura vasculaire récidivant et syndrome de Sjögren: quel lien? Pan Afr Med J 2015;22:92.
  52. Hunger RE, Dürr C, Brand CU. Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy. Dermatology (Basel, Switzerland) 2001;202(2):123-6.
  53. Dalia T, Liu D, Fraga GR, Springer J. A Rare Case of Sarcoidosis Presenting With Cutaneous Medium-Vessel Granulomatous Vasculitis Treated With Rituximab. J Clin Rheumatol 2018;24(1):1-4.
  54. Medaoud S, Hakem DJ, Moussaoui D, Boudjelida H, Abbaci K, Djenane, et al. Purpura vasculaire au cours de la sarcoïdose: à propos de deux observations. Rev Med Interne 2016;37(Suppl2):S153-S154.
  55. Ocakli B, Özmen I, Sonkaya E, Sertçelik L, Boga S, Türker H, et al. An Uncommon Coexistence of Sarcoidosis and Cutaneous Leukocytoclastic Vasculitis in an Adult. Indian J Dermatol 2019;64(6):486-9.
  56. Anver H, Dubey S, Banerjee S, Potter T, Short A, Ilchyshyn A. Recurrent strokes in a younger patient with rash: a case of Sneddon's syndrome. Rheumatol Adv Pract 2018;2(Suppl1):S25.
  57. Hello M, Barbarot S, Néel A, Connault J, Graveleau J, Durant C, et al. Manifestations cutanées associées aux gammapathies monoclonales. Rev Med Interne 2014;35(1):28-38.
  58. Visconti L, Cernaro V, Ferrara D, Lacava V, Alberto Ricciardi C, Di Mauro E, et al. [Periorbital purpura: a pathognomonic but late sign of AL amyloidosis]. G Ital Nefrol 2015;32(5):32.
  59. Chaulagain CP. Amyloid purpura of the breasts in a patient with systemic AL amyloidosis - Chaulagain - 2020 - British Journal of Haematology - Wiley Online Library. Br J Haematol 2020;189(6):1002.
  60. Öztürk E, Meltem Akay O, Ferhanoglu B. Recognizing Pinch Purpura as the First Manifestation of Light-chain Amyloidosis. Turk J Haematol 2018;35(3):208-9.
  61. Zhao J, Zhang R, Duan X, Xu Z, Li H, Gu F. A case of systemic amyloidosis beginning with purpura. Chin Med J 2012;125(3):555-7.
  62. Lestre S, Gonçalves A, Joao A, Ferreira A, Apetato M. [Purpura: primary systemic amyloidosis manifestation] - PubMed. Acta Med Port 2009;22(3):307-12.
  63. Alexander JS, Prokesch BC. What lies beneath: severe infection presenting as leucocytoclastic vasculitis. Lancet Infect Dis 2019;19(4):448.
  64. Shavit E, Alavi A, Sibbald RG. Vasculitis-What Do We Have to Know? A Review of Literature. Int J Low Extrem Wounds 2018;17(4):218-26.